Skip to main content

Gero

Gero

Type

investor

Founded

2018

Funding Rounds

1

Portfolio companies

1

About Gero

Gero is an AI-driven biotechnology company that builds physics-guided machine learning platforms and large health models to identify therapeutic targets and design interventions for aging and age-related diseases. The company applies interpretable generative models trained on longitudinal human health data to accelerate target discovery and preclinical drug development, and partners with pharmaceutical organizations to translate platform discoveries into therapeutics.

Gero investments captured (1)

Company NameStageTotal Deal AmountDate
Pre-Series A$1.5mDec 21, 2022